Siming Xu
About Siming Xu
Siming Xu is a scientist specializing in ex vivo genome editing, currently working at Mammoth Biosciences. He has extensive experience in CRISPR-Cas9 technology and has held positions at institutions such as ALSTEM, INC, Purdue University, and UCSF Medical Center.
Current Role at Mammoth Biosciences
Siming Xu currently serves as a Scientist specializing in Ex Vivo Genome Editing at Mammoth Biosciences. He has been with the company since 2021, contributing to advancements in genome editing technologies. His work focuses on the application of CRISPR-Cas9 technology in various research projects, enhancing the capabilities of the organization in the field of genetic engineering.
Previous Experience at ALSTEM, INC
Prior to his current position, Siming Xu worked at ALSTEM, INC as a Senior Scientist Group Lead from 2018 to 2021. During his three years in Richmond, California, he led projects that involved genome editing and contributed to the development of innovative solutions in the biotechnology sector.
Academic Background and Research at Purdue University
Siming Xu completed his Doctor of Philosophy (Ph.D.) in Plant Molecular Biology at Purdue University from 2010 to 2017. During this period, he also served as a Graduate Student Researcher and Teaching Assistant. His academic work laid the foundation for his expertise in molecular biology and genome editing technologies.
Research Assistant Role at Eberhard Karls Universität Tübingen
Siming Xu worked as a Research Assistant at Eberhard Karls Universität Tübingen from 2008 to 2009. This role provided him with valuable research experience in a European academic setting, enhancing his skills in molecular biology and contributing to his professional development.
Postdoctoral Research Fellowship at UCSF Medical Center
Siming Xu held a position as a Postdoctoral Research Fellow at UCSF Medical Center from 2017 to 2018. In this role, he focused on molecular and cell biology, further expanding his research capabilities and expertise in the field.